CO4930313A1 - Metodo para producir mamiferos transgenicos no humanos que producen oligosacaridos en su leche - Google Patents

Metodo para producir mamiferos transgenicos no humanos que producen oligosacaridos en su leche

Info

Publication number
CO4930313A1
CO4930313A1 CO98050804A CO98050804A CO4930313A1 CO 4930313 A1 CO4930313 A1 CO 4930313A1 CO 98050804 A CO98050804 A CO 98050804A CO 98050804 A CO98050804 A CO 98050804A CO 4930313 A1 CO4930313 A1 CO 4930313A1
Authority
CO
Colombia
Prior art keywords
transgene
milk
production
expression
oligosaccharids
Prior art date
Application number
CO98050804A
Other languages
English (en)
Inventor
Pedro A Prieto
John J Kopchick
Ricahrd D Cummmings
James M Pierce
David F Smith
W Moremen Kelley
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CO4930313A1 publication Critical patent/CO4930313A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/107—Rabbit
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)

Abstract

Un método para producir mamíferos transgénicos, no humanos,cuyas células somáticas y germinales contienen por lo menos un transgen, donde la expresión de por lo menos un transgen resulta en la producción de oligosacáridos y glicoproteínas en la leche de dicho mamífero, el método comprende las etapas de: (a) preparación de por lo menos un transgen, dicho por lo menos un transgen que contenga en asociación operable 1 ) por lo menos una secuencia de expresión reguladora funcional en las células secretorias mamarias, 2) una secuencia de ADN que codifica una secuencia de señal funcional en las células mamarias secretoras, y 3) una secuencia de ADN que codifica una enzima; (b) introducción de dicho por lo menos un transgen a un embrión mamífero no humano, y transferencia del embrión resultante a un receptor hembra; (c) identificación de por lo menos una cría hembra, en donde la expresión de dicho por lo menos un transgen resulte en la producción de por lo menos una enzima la cual que luego catalice la producción de oligosacáridos y glicoproteínas en la leche de dicho mamífero.
CO98050804A 1997-09-05 1998-09-04 Metodo para producir mamiferos transgenicos no humanos que producen oligosacaridos en su leche CO4930313A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/925,834 US6204431B1 (en) 1994-03-09 1997-09-05 Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk

Publications (1)

Publication Number Publication Date
CO4930313A1 true CO4930313A1 (es) 2000-06-27

Family

ID=25452320

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98050804A CO4930313A1 (es) 1997-09-05 1998-09-04 Metodo para producir mamiferos transgenicos no humanos que producen oligosacaridos en su leche

Country Status (20)

Country Link
US (1) US6204431B1 (es)
EP (1) EP1007651A1 (es)
JP (1) JP2001520001A (es)
KR (1) KR20010023645A (es)
CN (1) CN1273602A (es)
AR (1) AR017515A1 (es)
AU (1) AU9220398A (es)
BG (1) BG104236A (es)
BR (1) BR9811733A (es)
CA (1) CA2302777A1 (es)
CO (1) CO4930313A1 (es)
HU (1) HUP0004709A2 (es)
IL (1) IL133992A0 (es)
MX (1) MXPA00002266A (es)
NO (1) NO20001105L (es)
PL (1) PL339132A1 (es)
SK (1) SK3042000A3 (es)
TR (1) TR200000500T2 (es)
WO (1) WO1999011773A1 (es)
ZA (1) ZA987504B (es)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129745A1 (en) 1999-10-28 2003-07-10 Robl James M. Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
AU1777301A (en) * 1999-11-19 2001-05-30 Hematech, Llc Production of ungulates, preferably bovines that produce human immunoglobulins
US7074983B2 (en) * 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
US7414170B2 (en) * 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
US7820878B2 (en) * 1999-11-19 2010-10-26 Kyowa Hakko Kirin Co., Ltd. Production of ungulates, preferably bovines that produce human immunoglobulins
US8697394B2 (en) * 2000-06-28 2014-04-15 Glycofi, Inc. Production of modified glycoproteins having multiple antennary structures
US7863020B2 (en) 2000-06-28 2011-01-04 Glycofi, Inc. Production of sialylated N-glycans in lower eukaryotes
DE60114830T2 (de) * 2000-06-28 2006-08-03 Glycofi, Inc. Verfahren zur herstellung modifizierter glycoproteine
US7449308B2 (en) 2000-06-28 2008-11-11 Glycofi, Inc. Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
US7598055B2 (en) * 2000-06-28 2009-10-06 Glycofi, Inc. N-acetylglucosaminyltransferase III expression in lower eukaryotes
US7625756B2 (en) 2000-06-28 2009-12-01 GycoFi, Inc. Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
US6576464B2 (en) * 2000-11-27 2003-06-10 Geron Corporation Methods for providing differentiated stem cells
US6921665B2 (en) * 2000-11-27 2005-07-26 Roslin Institute (Edinburgh) Selective antibody targeting of undifferentiated stem cells
AU2002353374A1 (en) * 2001-12-21 2003-07-09 Nexia Biotechnologies, Inc. Production of butyrylcholinesterases in transgenic mammals
US20060253913A1 (en) * 2001-12-21 2006-11-09 Yue-Jin Huang Production of hSA-linked butyrylcholinesterases in transgenic mammals
US7169548B2 (en) * 2002-09-13 2007-01-30 Xy, Inc. Sperm cell processing and preservation systems
CA2502490A1 (en) * 2002-11-08 2004-05-27 Hematech, Llc Transgenic ungulates having reduced prion protein activity and uses thereof
US20040231010A1 (en) * 2003-01-09 2004-11-18 Murray James D. Lysozyme transgenic ungulates
US7332299B2 (en) * 2003-02-20 2008-02-19 Glycofi, Inc. Endomannosidases in the modification of glycoproteins in eukaryotes
US7514593B2 (en) * 2003-05-30 2009-04-07 The University Of North Carolina At Chapel Hill Animal model for chronic obstructive pulmonary disease and cystic fibrosis
US7771978B2 (en) * 2003-09-22 2010-08-10 Henrik Clausen β1,4mannosyltransferases
CA2548140A1 (en) * 2003-12-05 2005-06-23 University Of Massachusetts Oligosaccharide compositions and use thereof in the treatment of infection
WO2005080585A1 (en) * 2004-02-13 2005-09-01 Glycotope Gmbh Highly active glycoproteins-process conditions and an efficient method for their production
JP2007533328A (ja) 2004-04-22 2007-11-22 キリンホールディングス株式会社 トランスジェニック動物及びその用途
US20060053500A1 (en) * 2004-05-28 2006-03-09 Univ. of Pittsburgh of the Commonwealth System of Higher Education, Office of Technology Management Modification of sugar metabolic processes in transgenic cells, tissues and animals
JP5502328B2 (ja) * 2006-02-09 2014-05-28 メディカゴ インコーポレイテッド 植物体中でのシアル酸の合成
US7663019B2 (en) * 2006-05-24 2010-02-16 North Carolina State University Transgenic snakes and methods of making
US8124831B2 (en) * 2006-07-06 2012-02-28 Duke University Transgenic mice carrying functional single nucleotide polymorphisms in brain-specific tryptophan hydroxylase
US20090208480A1 (en) * 2006-08-04 2009-08-20 Yue Huang Long half-life recombinant butyrylcholinesterase
EP2631650B1 (en) 2007-09-07 2015-04-22 Children's Hospital Medical Center Composition comprising alpha-1,2 fucosyl glycans for treating gastrointestinal disorders
PT2217246E (pt) * 2007-11-08 2015-02-10 Nestec Sa Utilização de oligossacáridos contendo n-acetil-lactosamina para maturação de respostas imunes em recém-nascidos
CA2757169A1 (en) 2009-04-13 2010-10-21 Children's Hospital Medical Center Milk oligosaccharide compositions and use thereof in treating infection in animals
ES2660698T3 (es) * 2009-06-08 2018-03-23 Jennewein Biotechnologie Gmbh Síntesis de HMO
US9034847B2 (en) 2009-07-06 2015-05-19 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
MY189329A (en) 2009-07-15 2022-02-04 Nutricia Nv Mixture of non-digestible oligosaccharides for stimulating the immune system
EP2813230A1 (en) 2009-07-15 2014-12-17 N.V. Nutricia Fucosyllactose as breast milk identical non-digestible oligosaccharide for treating and/or preventing infections
US8729245B2 (en) 2009-12-21 2014-05-20 Pharmathene, Inc. Recombinant butyrylcholinesterases and truncates thereof
SG190260A1 (en) * 2011-01-06 2013-06-28 Univ Johns Hopkins Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells
WO2012168495A1 (es) 2011-06-07 2012-12-13 Hero Ag Obtención de oligosacaridos mediante un procedimiento biotecnológico
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
CN102839157A (zh) * 2012-07-12 2012-12-26 扬州大学 稳定共表达hST3GalIV和β1-4GalT1的MDCK细胞系及构建方法和应用
US20140115728A1 (en) 2012-10-24 2014-04-24 A. Joseph Tector Double knockout (gt/cmah-ko) pigs, organs and tissues
US10034921B2 (en) * 2013-02-13 2018-07-31 Laboratoire Français Du Fractionnement Et Des Biotechnologies Proteins with modified glycosylation and methods of production thereof
EP3594231A1 (en) 2013-02-13 2020-01-15 Laboratoire Français du Fractionnement et des Biotechnologies Highly galactosylated anti-tnf-alpha antibodies and uses thereof
US10626460B2 (en) 2013-02-21 2020-04-21 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
CN103196725B (zh) * 2013-03-26 2015-07-08 上海交通大学 制备与富集单个微纳米珠携带单根多聚物分子的方法
EP3288389A4 (en) 2015-04-28 2018-10-10 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
CA3105470A1 (en) 2018-07-11 2020-01-16 Ohio University Peptide-based inhibitors of growth hormone action and methods of use thereof
US11266129B2 (en) 2019-11-05 2022-03-08 Versiti Blood Research Institute Foundation, Inc. Murine model of fetal/neonatal alloimmune thrombocytopenia
CA3162639A1 (en) 2019-11-05 2021-05-14 Versiti Blood Research Institute Foundation, Inc. A murine model of fetal/neonatal alloimmune thrombocytopenia
AU2021395887B9 (en) * 2020-12-11 2023-11-02 Ausnutria B.V. Increased 2'-fl production by goats

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435363A (en) 1981-07-02 1984-03-06 Exxon Nuclear Company, Inc. Continuous countercurrent liquid-solids contactor
DE3334167A1 (de) 1983-09-21 1985-04-04 Siemens AG, 1000 Berlin und 8000 München Halbleiterdiode
GB8615942D0 (en) 1986-06-30 1986-08-06 Animal & Food Research Council Peptide production
US5322775A (en) 1986-06-30 1994-06-21 Pharmaceutical Proteins Ltd. Peptide production
AU7879987A (en) 1986-08-28 1988-03-24 Immunex Corp. Expression of heterologous proteins by transgenic lactating mammals
EP0279582A3 (en) 1987-02-17 1989-10-18 Pharming B.V. Dna sequences to target proteins to the mammary gland for efficient secretion
GB8826446D0 (en) 1988-11-11 1988-12-14 Agricultural & Food Res Peptide production
US5032519A (en) 1989-10-24 1991-07-16 The Regents Of The Univ. Of California Method for producing secretable glycosyltransferases and other Golgi processing enzymes
AU656720B2 (en) 1989-12-01 1995-02-16 Gene Pharming Europe Bv Production of recombinant polypeptides by bovine species and transgenic methods
EP0481038B1 (en) 1990-04-16 2002-10-02 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
WO1992003917A1 (en) 1990-08-29 1992-03-19 Genpharm International Homologous recombination in mammalian cells
US5198466A (en) 1990-11-09 1993-03-30 Warner-Lambert Company Oxysulfonyl urea acat inhibitors
US5362480A (en) 1991-12-31 1994-11-08 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing amino sugars as antiplaque agents
DK8892D0 (da) 1992-01-23 1992-01-23 Symbicom Ab Humant proteingen
US5401723A (en) 1992-12-02 1995-03-28 Colgate-Palmolive Company Glycoconjugate inhibition of Streptococcus pyrogenes adhesion
JPH08509467A (ja) 1993-02-26 1996-10-08 ノルマーク，ヤーン・スタツフアン 細菌接着のインヒビターとしてのオリゴ糖グリコシドの使用
DK76193D0 (da) 1993-06-25 1993-06-25 Astra Ab Kulhydratderivater
US5750176A (en) 1994-03-09 1998-05-12 Abbott Laboratories Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
EP0750671A1 (en) 1994-03-09 1997-01-02 Abbott Laboratories Transgenic animals producing oligosaccharides and glycoconjugates
CA2184687A1 (en) * 1994-03-09 1995-09-14 Pedro Antonio Prieto Humanized milk
US5625124A (en) 1994-07-11 1997-04-29 Washington University Animal model for helicobacter pylori infection
SK39498A3 (en) 1995-09-29 1999-01-11 Glycim Oy Synthetic multivalent slex containing polylactosamines and methods for use
US5874411A (en) 1995-11-13 1999-02-23 Glycomed Incorporated Oligosaccharide glycosides having mammalian immunosuppresive and tolerogenic properties
AU1122697A (en) 1995-11-22 1997-06-11 Research And Development Institute, Inc. Therapeutic and diagnostic agents for the treatment of microbial infections

Also Published As

Publication number Publication date
NO20001105L (no) 2000-05-05
BG104236A (en) 2000-12-29
SK3042000A3 (en) 2000-09-12
JP2001520001A (ja) 2001-10-30
KR20010023645A (ko) 2001-03-26
CN1273602A (zh) 2000-11-15
IL133992A0 (en) 2001-04-30
NO20001105D0 (no) 2000-03-03
WO1999011773A1 (en) 1999-03-11
EP1007651A1 (en) 2000-06-14
AR017515A1 (es) 2001-09-12
AU9220398A (en) 1999-03-22
HUP0004709A2 (hu) 2001-04-28
US6204431B1 (en) 2001-03-20
PL339132A1 (en) 2000-12-04
TR200000500T2 (tr) 2000-12-21
CA2302777A1 (en) 1999-03-11
ZA987504B (en) 1999-03-15
BR9811733A (pt) 2000-09-05
MXPA00002266A (es) 2000-10-01

Similar Documents

Publication Publication Date Title
CO4930313A1 (es) Metodo para producir mamiferos transgenicos no humanos que producen oligosacaridos en su leche
IL126416A0 (en) Cultured inner cell mass cell lines derived from ungulate embryos
CA2075206A1 (en) Production of recombinant polypeptides by bovine species and transgenic methods
BR9806872A (pt) Transferência nuclear com células diferenciadas doadoras fetais e adultas
MXPA01001389A (es) Transgenesis de mamifero por inyeccion de esperma intracitoplasmica.
GB2350619B (en) Sex-specific insemination of mammals with low number of sperm cells
CA2427322A1 (en) Methods for cloning mammals using reprogrammed donor chromatin or donor cells
AU2002361327A1 (en) Exogenous protein expression system in an avian system
ATE281516T1 (de) Verfahren zur herstellung von säugetieren mit definierten genetischen eigenschaften
AR007731A1 (es) Un metodo para producir una planta transformada de adn extrano dentro del cigote o embrion de un saco embrionario aislado.
ATE332077T1 (de) Transgene mäuse die ein menschliche antikörper exprimieren
EP0652889A4 (en) PRODUCTION OF RECOMBINANT POLYPEPTIDES BY BOVINE SPECIES AND TRANSGENIC PROCESSES.
Latham Cloning: questions answered and unsolved
Ono et al. Nuclear transfer preserves the nuclear genome of freeze-dried mouse cells
WO2000026357A3 (en) Transgenic and cloned mammals
Jitong et al. Cloned goats (Capra hircus) from adult ear cells
EP1375654A3 (en) Transgenic and cloned mammals
WO2000069257A3 (en) Genetic modification of male germ cells for generation of transgenic species and genetic therapies
GB2369828A (en) Nuclear transfer with selected donor cells
Hirabayashi et al. Factors influencing chromosome condensation and development of cloned rat embryos
NZ511808A (en) Transgenic bovine that produce the heterologous protein in milk
ATE364693T1 (de) Verfahren zur herstellung von nicht-humanen geklonten und transgenen säugetieren
Kato et al. Nuclear transplantation of mouse fetal germ cells into enucleated two-cell embryos
Tsunoda et al. Viability of blastocysts and morulae cultured from 1-cell stage and transferred to recipients in the mouse
BR0010588A (pt) Oócitos enucleados de telofase para transferência nuclear